Position in MLEC
as of Mar 31, 2026
· filed Apr 30, 2026
Position Value
$0
New position
Shares Held
25,000
first reported quarter
Ownership
3.44%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Position in Biotechnology
Healthcare · as of Jun 30, 2026Kestra Advisory Services, LLC holds $29,012,263 across 51 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
15,732 | $7,814,556 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,893 | $1,803,901 | |
| 3 | RPRX |
Royalty Pharma plc
|
27,331 | $1,532,449 | |
| 4 | 39,421 | $1,239,002 | |||
| 5 | VKTX |
Viking Therapeutics, Inc.
|
27,091 | $1,056,819 | |
| 6 | IBRX |
ImmunityBio, Inc.
|
110,630 | $968,565 | |
| 7 | CORT |
Corcept Therapeutics Inc
|
10,914 | $948,972 | |
| 8 | CRSP |
CRISPR Therapeutics AG
|
17,292 | $943,105 |
All Filings in MLEC
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 MLECW | — | 25,000 | Shares | Sole | 2026-04-30 | |
| No filing history on record for this holder in this stock. | ||||||